Across TCGA pan-cancer cohorts, RNA5SP502 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RNA5SP502 data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher RNA5SP502 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNA5SP502 expression acts as an unfavorable survival marker, although some lineages such as OV and BLCA show a favorable association.
KICH, KIRC, and ACC are the cancer types where RNA5SP502 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.